Literature DB >> 9085956

The use of 0.25% lidocaine with fentanyl and pancuronium for intravenous regional anesthesia.

F Sztark1, M Thicoipé, J F Favarel-Garrigues, P Lassié, M E Petitjean, P Dabadie.   

Abstract

The present study was designed to assess the efficacy of fentanyl and pancuronium combined with dilute lidocaine solution for intravenous regional anesthesia of the arm. Forty adult patients undergoing upper limb surgery were randomly allocated to receive either 0.6 mL/kg of 0.5% lidocaine (3 mg/kg) or 0.6 mL/kg of 0.25% lidocaine (1.5 mg/kg) with 1 microg/kg of fentanyl and 0.5 mg of pancuronium. The onset of sensory and motor blocks was significantly shorter in the 0.5% lidocaine group (P < 0.05). However, no differences in analgesia or motor blockade were found between the two groups at 20 min tourniquet time. Regional anesthesia was considered successful in more than 85% of patients. One patient in the 0.25% lidocaine group experienced a transient diplopia after tourniquet release. Postoperative analgesia time was similar in the two groups. We conclude that the addition of fentanyl plus pancuronium to the lidocaine solution reduces the dose of the local anesthetic and possibly systemic toxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085956     DOI: 10.1097/00000539-199704000-00014

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  A Comparison Between the Effectiveness of Ketamine Bolus and Intradermal Lidocaine in Reducing Acute Postoperative Pain.

Authors:  M Fahad Najam; Nusrat Jafri
Journal:  Cureus       Date:  2022-07-04

2.  Intravenous regional anesthesia: a review of common local anesthetic options and the use of opioids and muscle relaxants as adjuncts.

Authors:  David Flamer; Philip Wh Peng
Journal:  Local Reg Anesth       Date:  2011-11-25

3.  The quaternary lidocaine derivative QX-314 produces long-lasting intravenous regional anesthesia in rats.

Authors:  Yi Zhao; Cheng Zhou; Jin Liu; Peng Liang; Daqing Liao; Yanfang Chen; Xiangdong Chen
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.